{"brief_title": "Study of FK463 for the Treatment of Invasive Aspergillosis", "brief_summary": "The purpose of the study is to evaluate the safety and efficacy of FK463 in patients with proven or probable invasive infections due to Aspergillus species.", "detailed_description": "This will be an open-label, non-comparative study of intravenous FK463. Enrollment will include at least 100 patients evaluable for efficacy.", "condition": "Aspergillosis", "intervention_type": "Drug", "intervention_name": "FK463", "criteria": "Inclusion Criteria - Has proven or probable systemic infection with Aspergillus species Exclusion Criteria - Has abnormal liver test parameters, e.g., AST or ALT > 10 times upper limit of normal - Has bronchopulmonary aspergillosis, aspergillomas, sinus aspergillosis or external otitis but does not have histologic evidence of tissue invasion - Has life-expectancy judged to be less than 5 days", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00036166.xml"}